Displaying drugs 7976 - 8000 of 9273 in total
ZYCOV-D
The ZYCOV-D vaccine candidate was developed by Cadila Healthcare Ltd. based in India . The vaccine was developed using a DNA vaccine platform with a non-replicating and non-integrating plasmid carrying the gene of interest . Once the plasmid DNA is introduced into host cells and the viral protein is translated,...
Investigational
Matched Description: … As of August, 2020 the candidate is in Phase II clinical trials[A219758]. ... using a DNA vaccine platform with a non-replicating and non-integrating plasmid carrying the gene of ... is translated, it elicits a strong immune response, stimulating the humoral and cellular components of …
MX6
MX6 is adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. More specifically, it has been shown that such adamantyl compounds, e.g., 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, 2-[3-(1-adamantyl)-4-methoxyphenyl]-5-benzimidazole carboxylic acid, and 6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthoic acid, can be used to treat...
Investigational
Matched Description: … and therefore may be used for the treatment of cancer, including advanced cancer. ... MX6 is adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells …
Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
Human olfactory mucosa-derived mesenchymal stem cells (OM-MSCs) reside in an accessible location of the nasal cavity and have properties of multipotency and high proliferation, which contributes to high potential for regenerative medicine. In humans, OM-MSCs are derived from the olfactory mucosa which is collected in vivo through rhinoscopy techniques and...
Investigational
Matched Description: … Human olfactory mucosa-derived mesenchymal stem cells (OM-MSCs) reside in an accessible location of the ... nasal cavity and have properties of multipotency and high proliferation, which contributes to high potential …
CoviGlobulin
CoviGlobulin, a rabbit polyclonal antibody, was specifically designed as a potential therapy for COVID-19. Rabbit polyclonal antibodies are derived from the rabbit, a common animal host for polyclonal production. The antibodies themselves are produced in response to an immunogen and derived from antibody-producing plasma cells that were once B-cell clones....
Investigational
Matched Description: … Different antibodies have different mechanisms of action depending on their target. ... Current applications of antibodies include, but are not limited to, targeting cancer, inflammatory diseases …
Distigmine
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
Matched Description: … Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation ... carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of ... Distigmine is available in several countries as a treatment of underactive detrusor and voiding dysfunction …
Norvaline
Norvaline is an isomer of the more common amino acid valine.
Experimental
Matched Description: … Norvaline is an isomer of the more common amino acid valine. …
BMS-690514
BMS-690514 has been investigated for the treatment of Breast Cancer.
Investigational
Matched Description: … BMS-690514 has been investigated for the treatment of Breast Cancer. …
E-6201
E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.
Investigational
Matched Description: … E6201 has been investigated for the treatment of Chronic Plaque Psoriasis. …
Carnosine
Carnosine has been investigated for the treatment of Gulf War Illness.
Investigational
Matched Description: … Carnosine has been investigated for the treatment of Gulf War Illness. …
Fedovapagon
Fedovapagon has been used in trials studying the treatment of Nocturia.
Investigational
Matched Description: … Fedovapagon has been used in trials studying the treatment of Nocturia. …
Arhalofenate
Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Investigational
Matched Description: … Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia. …
Tegobuvir
Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Description: … Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic. …
Vistusertib
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
Matched Description: … Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma. …
Vosaroxin
Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.
Investigational
Matched Description: … Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. …
Vanutide cridificar
Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Description: … Vanutide cridificar has been investigated for the treatment of Alzheimer Disease. …
Cordycepin
Cordycepin has been used in trials studying the treatment of Leukemia.
Investigational
Matched Description: … Cordycepin has been used in trials studying the treatment of Leukemia. …
Dalcetrapib
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Matched Description: … Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome. …
Zicronapine
Zicronapine has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … Zicronapine has been used in trials studying the treatment of Schizophrenia. …
Defactinib
Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma.
Investigational
Matched Description: … Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma. …
Anrukinzumab
Anrukinzumab has been used in trials studying the diagnostic of Asthma.
Investigational
Matched Description: … Anrukinzumab has been used in trials studying the diagnostic of Asthma. …
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Intetumumab
Intetumumab has been used in trials studying the treatment of Melanoma.
Investigational
Matched Description: … Intetumumab has been used in trials studying the treatment of Melanoma. …
Pilsicainide
Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Investigational
Matched Description: … Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation. …
GET-73
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
Matched Description: … Get 73 has been investigated for the treatment of Alcohol Dependence. …
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Matched Description: … TBD has been used in trials studying the treatment of Adenocarcinoma. …
Displaying drugs 7976 - 8000 of 9273 in total